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The H-2  gene complex of the mouse is comprised of four distinct regions, K  and D, 
marked by genes which control histocompatibility antigens, S, defined by a gene(s) for 
the Ss serum protein (C'4 component) and Slp allotype traits, and I, which include genes 
controlling immune responses, lymphocyte-activating determinants (Lad), ~ graft-versus- 
host reaction,  immune response-associated (Ia) antigen,  and a histocompatibility locus 
(1-3).  The I  region has been further divided into subregions, I-A, I-B, I-J, I-E, and I-C, 
which control different sets of specific immune responses or suppression (4). 
I-C subregion was defined by specificity Ia.6 which differentiated H-2 k (Ia.6-) and H- 
2 '1  (Ia.6+) haplotypes for this  subregion  (2). I-E  subregion was defined by specificity 
Ia.22, positive in H-2 k and negative in H-2 ~z (4). Recently, we identified a new private Ia 
specificity (Ia.23) of H-2 '~ origin, also mapping in I-E subregion. 2 Sequential precipitation 
studies  suggest that specificities Ia.7, 22  (H-2 k)  and Ia.7,  23  (H-2 d)  are expressed on 
products coded by I-E subregion gene(s). 3 That leaves Ia.6 as the only specificity mapping 
in the I-C subregion. 
Previous  investigations  have  shown  that  genes  controlling  products  which  cause 
stimulation  in  the  mixed  lymphocyte reaction  (MLR)  map in  a  number of different 
regions of the H.2  gene complex (5, 6). The strongest MLR stimulation has been seen 
with I region differences. Specific loci controlling Lad were identified in the I-A and I-C 
subregions (7). Recently, we identified a Lad locus expressed exclusively on T cells and 
mapping in the I-J  subregion  (8). Previous MLR studies  with the I-C  subregion also 
included incompatibility at I-J and I-E subregions (9). 
By using recombinant strains of mice which differ for I-C (including S  and G) 
subregion (A and A.AL; B10.AM and B10.A(2R)) or combinations with only/-C 
incompatibility [(A  ×  C3H.OL)F1 and A.AL], we have attempted to test for the 
existence of a Lad  locus in this subregion.  Our results show that I-C subregion 
gene(s) code for MLR determinants on T cells. I-C subregion also code for genes 
involved in  the  alloantigen-mediated  MLR suppressor factors (10,  11),  a-gene 
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for response to random linear terpolymer of L-glutamic acid,  L-lysine,  and L- 
phenylalanine (GLcb) (12),  determinants on Fc receptor  positive  (FcR+)T  cells 
(13) and possibly other T-cell functions. 
Materials and Methods 
Mice and Alloantisera.  Inbred strains, recombinants, and FI hybrids used in this study were 
all produced in the Department of Genetics mouse colony at Washington University School of 
Medicine,  St.  Louis,  Mo.  A  battery  of anti-Ia  and  anti-H-2  antisera  were  produced  in  our 
laboratories, as previously described (14). 
Cell Preparation.  Thymus cells, spleen cells, and lymph node cells were used as T-cell sources. 
Purification of T cells was performed by passing the lymph node cell suspensions through nylon 
wool columns (15). 
Separation of B  cells from spleen cells was performed as follows: spleen cells  (5  ×  107) were 
reacted with anti-Thy-l.2 serum (provided by the Transplantation Branch, National Institutes of 
Allergy and Infectious Diseases, Bethesda, Md.) at a final concentration of 10% antiserum in 5% 
fetal calf serum-containing RPMI 1640 medium. After 30 rain at 37°C,  the cells were washed twice 
with Hanks' balanced salt solution (HBSS). Rabbit complement was added and the mixture was 
incubated for an additional 40 min at 37°C,  in a  humidified atmosphere containing 5% carbon 
dioxide. For absorption of anti-Ia sera, bone marrow cells were used as a source of B cells (16). 
Macrophages  were  collected  by  washing  the  normal  mouse  peritoneal  cells  with  HBSS. 
Thereafter, the peritoneal cell suspension was placed into tissue culture dishes (Coming Glass 
Works,  Coming,  N.Y.)  for  60  min  and  nonadherent  cells  removed.  The  adherent  cells  were 
collected and after one more 60 rain incubation, were used as the source of macrophages. 
Cytotoxic  Test.  Two-stage  dye-exclusion microcytotoxic tests were  performed  as  previously 
described (14). 
Absorption ofAnti-Ia Antisera.  100 A of antiserum (B10.K  ×  A.TL)F1 anti-A (anti-l-C  d, S 't, 
G ~) was diluted 1/10 with a  modified Eagles'-Hanks' medium (EHAA) (17) containing 2% human 
plasma, and adsorbed with 1  ×  l0  s cells of (a) macrophages,  (b) B cells (bone marrow cells), and 
(c) T cells, respectively, ofB10.A(2R) (I-C  d) mice, at 37°C for 60 min. After incubation, supernates 
were assayed for their ability to inhibit MLR response by using B10.AM (I-C  ~) T cells as responder 
and B10.A(2R) (I-C a) T cells as stimulator. 
Mixed Lymphocyte Reaction Assay.  The medium employed in this assay was an EHAA medium 
supplemented with 2% human plasma. 5 ×  105 viable responder cells were cultured with 1.0 ×  106 
mitomycin C-treated  stimulator cells  (18)  in 0.2  ml of medium  in  microculture plates  (Falcon 
3040,  BioQuest, BBL & Falcon Products, Becton, Dickinson & Co., Cockeysville, Md.). Incubation 
was performed at 37°C in a 5% carbon dioxide, 95% air, humidified atmosphere for 72 h. 2 ~Ci of 
[SH]thymidine (sp.  act 1.9 Ci per mmol, New England Nuclear,  Boston,  Mass.) was then added 
and the culture was harvested after a further 16 h. Within each experiment the mean and SD are 
calculated from three replicate wells. The experiments were repeated three to six times to check 
for repeatability of results and stimulation index. 
Inhibition of MLR.  MLR assays were done by the technique described above. 5  ×  l0  s nylon 
wool-purified responder T cells were cocultured with 1.0  ×  10  ~ mitomycin C-treated, nylon wool- 
purified stimulator  cells  in  the presence  of 1.25%  heat-inactivated alloantiserum,  or  normal 
control serum, in a total vol of 200 pl. Percent inhibition was calculated according to the following 
formula: 
Percent inhibition = 
I  -  cpm of allogeneic culture in antiserum-cpm of syngeneic culture in NMS~  -j  ×  lOO. 
Treatment of Ia-Antisera and  Complement.  Nylon  wool-purified  T  cells  were  reacted  with 
antiserum or control normal mouse serum (NMS), at a  final concentration of 10%,  in RPMI-1640 
containing 2.5% heat-inactivated human plasma.  After incubation for 30 min at 37°C,  the cells 
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rabbit complement  (19).  After incubation for 90 min at 37°C,  the dead cells were counted and 
separated from live cells on a Ficoll-Hypaque gradient. Dead cells in these tests were scored by a 
dye exclusion test.  Only surviving cells,  after the treatment by antisera and complement (and 
followed by mitomycin C treatment), were used as stimulator cells in these MLR tests.  Culture 
media,  cell  numbers of stimulators  and responders,  the  period of culture,  and the  method  of 
harvesting were all the same as those described above. No antisera were added to the media for 
elimination studies. Percent inhibition was estimated by the formula: 
Percent inhibition = 
1 _cpm of allogeneic culture of treated cells-cpm of syngeneic cultur~ 
cpm of allogeneic culture-cpm of syngeneic culture  ]-  ×  100. 
Results 
Mixed Lymphocyte Reaction Across I-C Subregion.  Strain combinations A- 
A.AL and B10.AM-B10.A(2R) were used in one-way MLR tests to detect Lad 
determinants controlled by the I-C subregion. These strains differ in I-C, S, and 
G regions (Table I). As shown in Table II, when lymph node cells were used as 
stimulators and responders,  a  significant MLR response was seen. In general, 
I-C  d strains  were  better  stimulators  than  the I-C  ~ strains.  To  rule  out  the 
contribution of S  and G regions (as well as TL and Q regions),  (A × C3H.OL)F1 
animals  were  used  as  the  responding  strains  and  A.AL  as  the  stimulating 
strains.  Substantial stimulation was detected which should be due only to MLR 
determinants  mapping in the PC subregion. This experiment was repeated six 
times and similar results were obtained. 
The  Origin  of the  Stimulator  Cell.  Mitomycin  C-treated  stimulator  cells 
from strain A and untreated responder lymph node cells from A.AL mice were 
cocultured to detect the population of cells stimulating across the I-C subregion. 
The  stimulator  cell populations  used,  were spleens,  lymph  nodes,  thymuses, 
purified T  cells and B  cells.  As shown in Table HI thymus cells showed very 
weak stimulation  and spleen cells displayed intermediate  stimulation.  Cocul- 
tures with the lymph node cells yielded stimulation index of 2.79. 
Purified T  cells  and  B  cells were  used in  subsequent experiments.  T  cells 
were purified by nylon wool passage while B cells were purified by treatment 
with anti-Thy-l.2  serum.  The stimulation  index was about 1.05  when B  cells 
were used. When nylon wool-purified T cells were employed as stimulators, the 
stimulation  index  increased  to  about  3.3.  This  result  suggests  that  Lad 
determinants  of I-C subregion are primarily expressed on T cells. This experi- 
ment was repeated three times with similar results. 
Inhibition of MLR Response by Anti-Ia Sera.  Nylon wool-purified T cells of 
(A  x  C3H.OL)F1 hybrids were cocultured with nylon wool-purified mitomycin 
C-treated A.AL T cells in the presence of various anti-Ia sera (Table IV). Strong 
inhibition was observed in the presence of antisera A anti-A.AL (anti-I-C k, S k, 
G k) and B10.S(9R) anti-B10.HTT (anti-I-J s, I-C  k, S k, Gk). Both of these antisera 
lack  cytotoxic activity  against  unfractionated  spleen  cells  but  could  contain 
antibodies against I-C  k region products. However, antisera (C3H. Q × B 10. D2)F1 
anti-AQR  (anti-I-A k, I-B k, I-J  k, I-E  k) and C3H.OH anti-C3H.OL  (anti-S k, Gk), 
which lacked antibodies against antigens coded by I-C subregion, failed to give 
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TABLE  I 
H-2 Gene Complex of Selected Recombinants 
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H-2 Haplo- 
Strain 
type 
H-2 Regions 
K  A  B  J  E  C  S  G  D  TL 
A  a  k  k  k  k  k  d  d  d  d  a 
A.AL  a/  k  k  k  k  k  k  k  k  d  c 
C3H.OL  ol  d  d  d  d  d  d  k  k  k  b 
C3H.OH  o2  d  d  d  d  d  d  d  d  k  b 
B10.AM  h3  k  k  k  k  k  k  k  k  b  b 
B10.A(2R)  h2  k  k  k  k  k  d  d  ?  b  b 
B10. HTT  t3  s  s  s  s  k  k  k  k  d  c 
B10.S(9R)  t4  s  s  ?  k  k  d  d  d  d  a 
TABLE  II 
MLR Responses of Lymph Node Cells among I-C Subregion  Differing Strains 
Responder  Stimulater*  Incompatible  cpm of [SH]TdR*  Stimula- 
region  (mean -+  SD)  tion indices 
B10.AM  BI0.AM  -  970.8 ±  131  - 
BI0.AM  BI0.A(2R)  C, S, G  4,832.0 ±  420  5.0 
B10.A(2R)  B10.A(2R)  -  3,201.6  ±  481  - 
B10.A(2R)  B10.AM  C, S, G  5,442.9 -+ 1,966  1.7 
A  A  -  1,609.5  ±  224  - 
A  A.AL  C, S,  G  5,020.1  ±  439  3.1 
A.AL  A.AL  -  2,381.6  ---  293  - 
A.AL  A  C, S, G  7,918.5  ±  386  3.3 
(A  x  C3H.OL)F~  (A  x  C3H.OL)F,  -  2,526.7  ±  174  - 
(A  ×  C3H.OL)F~  A.AL  C  10,733.8  ±  709  4.2 
* Mitomycin  C-treated cells. 
$ Represents  mean  and SD of three replicate  wells. 
by TL and Q loci, but the stimulator and responder are compatible for these two 
regions. Further, anti-Thy-l.2 antiserum as well as anti-H-2K  k and anti-H-2D d 
failed to inhibit.  These results also suggest that MLR observed in the combina- 
tion (A ×  C3H.OL)F1 versus A.AL is also due toI-C gene products and that the 
antisera  made across I-C incompatibility contain antibodies against Lad  gene 
products of this region. 
To confirm the above results with anti-I-C  d sera,  B10.AM cells were used as 
responders  and  B10.A(2R) cells  as  stimulators.  In  this  combination S  and  G 
regions  (and  TL  and  Q)  are  also  incompatible.  All  the  antisera  that  could 
contain antibodies against I-C  ~ region products inhibited the MLR. To test the 
target  cell  involved  in  this  inhibition,  antiserum  (B10.K  ×  A.TL)F1  anti-A 
(anti-I-C ~, S ~, G d) was absorbed with purified B cells, T cells, and macrophages, 
respectively. Antisera absorbed with bone marrow cells (B cells) and peritoneal 
macrophages of B10.A (2R) (I-C  ~) still gave substantial levels of MLR inhibition. 
When  the  antiserum  was  absorbed  with  nylon  wool-purified  T  cells  from 
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TABLE HI 
MLR Responses of Lymph Node Cells Stimulated  by Thymocytes, Spleen Cells, 
Lymph Node Cells, B  Cells, and T Cells Incompatible for I-C Subregion 
Responder  cpm of [3H]TdR  Incorporation 
(lymph node  Stimulator*  Experiments (mean _+  Stimula- 
cells)  SD)  tion indices 
A.AL  A.AL (Spleen)  4,571.6  ±  283  - 
A.AL  A  (Spleen)  10,015.1  ±  734  2.19 
A.AL  A.AL (Thymus)  1,786.3  ±  481  - 
A.AL  A  (Thymus)  1,933.2  -+ 260  1.08 
A.AL  A.AL (Lymph node)  4,467.9  -+ 235  - 
A.AL  A  (Lymph node)  12,480.6  ±  791  2.79 
A.AL  A.AL (B Cells)§  4,950.1  ±  312  - 
A.AL  A  (B Cells)  5,218.3  -+  1,071  1.05 
A.AL  A.AL (T Cells)ll  4,162.6  ±  223  - 
A.AL  A  (T Cells)  13,766.0  -+  1,942  3.30 
* Mitomycin C-treated cells. 
$ Mean and SD of three replicate wells. 
§ Prepared by  treatment of spleen cells with anti-Thy-l.2  +  C'.  About  90%  cells were 
immunoglobulin-positive cells. 
II Prepared by nylon wool column. About 90% cells were Thy-l.2 antigen positive. 
that  I-C  gene  products  are  expressed  on  T  cells  and  not  on  B  cells  and 
macrophages. 
In  an  attempt  to rule  out the  possibility that  antibodies  against  S  and  G 
region products are involved in the above MLR inhibitions,  the antisera  were 
absorbed  with  C3H.OL  lymphocytes.  C3H.OL  (I-C ~,  S k,  G ~')  removes  the 
inhibiting  capacity  of (B10.K  x  A.TL)F1  anti-A  (anti-I-C ~,  S d,  G d)  but  not 
B10.S(7R) anti-B10.HTT  (anti-I-E k, I-C ~', S k,  Gk).  Thus,  removal of antibodies 
against the S  and G regions does not affect inhibition of I-C incompatible MLR. 
These results  also indicate that putative antibodies against  TL  and Q  region 
antigens do not cause inhibition. 
Elimination  of Stimulating  Cells  with Anti-Ia  +C'.  We next investigated 
the ability of various anti-Ia sera to eliminate the stimulating cell population in 
the presence of complement.  Nylon wool-purified T cells of B10.AM mice were 
incubated  with  anti-Ia  sera  and  rabbit  complement.  The  dead  cells  were 
eliminated by centrifugation on Ficoll-Hypaque and the viable T cells were used 
as  stimulators.  As  shown  in  Table  V  antisera  directed  against  I-C ~"  region 
products eliminated the stimulating cells. Antiserum  (B10.A(4R) x  C3H.OL)F1 
anti-B10.K  could  not  contain  antibodies  against  TL  or  Q  region  antigens. 
Antisera  directed  against I-A k,  I-B k,  I-J k,  I-E k,  S k,  G k  had  no  effect.  These 
results suggest that the I-C gene products are expressed on a subpopulation of T 
cells which does not express the other I subregion products. As expected anti-H- 
2K  k, anti-H-2D b, and anti-Thy-l.2 eliminated the MLR response. KENJI  OKUDA  AND  CHELLA  S.  DAVID  1033 
TABLE IV 
Effects of Anti-Ia Sera on MLR Responses between A.AL T Cells as Stimulator and T 
Cells of (C3H.OL  × A)F, Hybrids as Responder 
[3H]TdR In- 
Inhibi- 
Responder*  Stimulator*  Treatment§  Region  corporation  tion¶ 
(mean  .+  SD)I[ 
% 
A  ×  C3H.OL  A  ×  C3H.OL  NMS  635.0  .+  120  - 
A  x  C3H.OL  A.AL  NMS  3,281.3  .+  278  - 
A  ×  C3H.OL  A.AL  B10.S(7R)  Anti-  (E,  C, S, G)  k  1,660.5  _+ 234  61 
B10. HTT 
A  ×  C3H.OL  A.AL  A  Anti-A.AL  (C,  S, G)  k  2,071.1  _  563  46 
A  ×  C3H.OL  A.AL  B10.S(9R)  Anti-  Jg (C,  S,  G) k  1,254.7  -  310  77 
B10.HTT 
A  ×  C3H.OL  A.AL  (C3H.Q  ×  B10.D2)FI  (A, B, J,  E) k  2,890.9  .+  237  15 
Anti-AQR 
A  ×  C3H.OL  A.AL  A.TL Anti-A.AL  K k  2,658.3  -+ 325  24 
A  ×  C3H.OL  A.AL  (B10.K  ×  A.TL)F1  (C, S, G)  d  2,850.3  -+  180  26 
Anti-A 
A  x  C3H.OL  A.AL  C3H.OH  Anti-  (S,  G)  k  2,973.1  -+ 268  12 
C3H.OL 
A  ×  C3H.OL  A.AL  (B10.AKM ×  ASW)F,  D d  3,146.0  .+ 519  5 
Anti-A.TH 
A  ×  C3H.OL  A.AL  Anti-Thy.l.2  3,011.7  -+ 271  10 
* Nylon wool-purified T  cells. 
$ Mitomycin C-treated T  cells. 
§ Serum at 1.25% final dilution in the culture. 
H Mean and SD from three replicate  wells. 
[  allogeneic  MLR  in  anti-la  s  era-syngeneic MLR in  NMS 
¶ Inhibition = ~1 -  allogeneic  MLR  in  NMS  - syngeneic MLR in NMS  ] × 100. 
Discussion 
Specificity Ia.6 was defined as a private specificity of H-2 ~ haplotype mapping 
in the I-C  a subregion. Haplotype H-2 a was positive for Ia.6 which suggested the 
expression  of I-C  d  segment  in  that  strain.  Ia.6  specificity exhibited  several 
unique qualities.  Only 15-20% of lymph node cells were lysed by anti-Ia.6  and 
the antibodies were detected only in the early bleedings and were IgM in nature 
(20).  The  antisera  reacted  with  some  T-cell  lymphomas.  After  the  original 
antisera  was exhausted we were unable  to produce other sera  with cytotoxic 
activity. Further,  we were unable to detect Ia.6 by immunoprecipitation  assay 
by using  spleen  cells  (Cullen,  unpublished  observations).  These  results  sug- 
gested that Ia.6 may be a  T-cell specificity. Recent results indicate that Ia.6 is 
expressed on a  subpopulation  of T  cells from I d strains  mapping  in I-C.  H-2 a 
haplotypes and the recombinants derived from it express this antigen. 
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TABLE V 
Anti-Ia Elimination of MLR Response Among BIO.A(2R) T Cells as Responder and 
BIO.AM as Stimulator 
Re-  [aH]TdR In-  Inhibi- 
sponder*  Stimulators  Pretreatment§  Region  corporation  tion 
(mean +_ SD) 
% 
B10.A(2R)  B10.A(2R)  NMS + C'  (-)  4,324.3 _+ 459  - 
B10.A(2R)  B10.AM  NMS + C'  (-)  7,386.0 _+ 521  - 
B10.A(2R)  B10.AM  (B10.A(4R)  x C3H.OL)F,  (B, J, E, C)  k  4,056.6 _+ 108  100 
Anti-B10.K + C' 
B10.A(2R)  B10.AM  B10.S(7R)  Anti-B10.HTT  Js(C,  S,  G) k  4,418.5 -+ 317  97 
+ C' 
B10.A(2R)  B10.AM  C3H.OH  Anti-C3H.OL +  (S,  G) k  7,035.8 _+ 561  11 
C' 
B10.A(2R)  B10.AM  (A.TH  x  B10.HTT)F,  (A, B, j)k  6,703.2  -+ 837  22 
Anti-A.TL + C' 
B10.A(2R)  B10.AM  B10.A(3R)  Anti-  jk  6,814.1 _+ 710  19 
B10.A(5R) + C' 
B10.A(2R)  B10.AM  A.TL Anti-A.AL + C'  K  k  3,976  100 
BI0.A(2R)  BI0.AM  Anti-Thy-l.2 + C'  3,033  100 
* Nylon wool-purified T cells. 
* Mitomycin C-treated T cells. 
§ Stimulator cell treated with 1/lO serum plus AS-absorbed rabbit complement, then washed. 
of  I-E and I-C subregions. Sequential immunoprecipitation experiments suggest 
that Ia.22 and Ia.7 are expressed on the same molecule. 3 Further, Ia.23 and Ia.7 
are  also  expressed  on the  same  molecule. 2 The  map  positions  of specificities 
Ia.7,  22  and  23  seem  to  fall  within  the  I-E  subregion,  Ia.7  being  a  public 
specificity  while  Ia.22  and  23  are  private  specificities  of I k  and  I d  strains, 
respectively.  Thus  specificities  with  predominant  expression  on  B  cells  map 
within the I-E  subregion while Ia.6 expressed on T  cells  map within the I-C 
subregion. 
The mixed lymphocyte reaction studies in strain combination of A-A.AL and 
B10.AM-B10.A(2R) indicate a Lad locus controlled by the I-C subregion. When 
(A  ×  C3H.OL)F1 is used as responder and A.AL as stimulator,  the incompati- 
bility should only be at I-C subregion.  Antisera made across I-C incompatible 
strains  which  do not exhibit  cytotoxic activity on spleen  cells can inhibit the 
MLR reaction.  Even  though  some  of these  antisera  could contain  antibodies 
against gene products of TL and Q  regions, they do not seem to be involved in 
the  inhibition.  The antibodies are  directed against the  MLR determinants  on 
the stimulator cells.  Further,  absorption of these antisera with purified T  cells 
removes the  inhibiting ability while purified  B  cells  and macrophages do not 
seem to play a  role. KENJI  OKUDA  AND  CHELLA  S.  DAVID  1035 
Our results and those of others suggest that I-C subregion gene(s) codes for 
products  expressed  selectively on  a  subpopulation  of T  cells.  The  following 
immunological traits have been  mapped to the I-C  subregion;  (a)  a-gene for 
response to GLib; (b) gene controlling generation and acceptance of alloantigen- 
mediated suppressor factors; (c)  determinants on FcR  + T  cells;  (d) specificity 
Ia.6, and (e)  MLR simulating determinants. The number of genes involved in 
the control or regulation of the above phenomena remain to be seen. 
Summary 
A new lymphocyte-activating determinant (Lad)  locus expressed on T  cells 
was identified, mapping in the I-C subregions of H-2 k and H-2 ~ haplotypes. The 
mixed lymphocyte reaction stimulation could be inhibited by anti-Ia sera made 
in  strains  incompatible  for  this  chromosomal  segment.  Experiments  with 
purified lymphocyte cell  populations suggested that  this Lad  locus  was  ex- 
pressed  on  T  cells.  Further,  only purified T  cells  were  able  to  remove  the 
inhibiting activity from the anti-Ia sera. I-C subregion gene(s) seem to code for 
products selectively expressed on a subpopulation of T cells. 
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